Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule classified as a D-alpha-amino acid derivative. It has not been approved for clinical use in any country and is considered experimental, with no reported indications or clinical trials beyond preclinical research. The precise mechanism of action, biological targets, and therapeutic applications are not described in the available literature. Its structure features an acetic acid core substituted with ethoxy, fluoro, tetrahydrofuran-yloxy, and carbamimidoyl groups on aromatic rings[1][7][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2R)-({4-[amino(imino)methyl]phenyl}amino){5-ethoxy-2-fluoro-3-[(3R)-tetrahydrofuran-3-yloxy]phenyl}acetic acid.